Lisa Winston, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency Internal Medicine

    Collapse Overview 
    Collapse Overview
    Lisa Winston received her MD from Johns Hopkins University School of Medicine in 1994. She completed her residency in Internal Medicine at UCSF and was Chief Resident at San Francisco General Hospital. Dr. Winston then completed fellowships in Infectious Diseases and Clinical Pharmacology at UCSF.

    She directs the Inpatient Medical Services and is the Hospital Epidemiologist at Zuckerberg San Francisco General Hospital and Trauma Center. Her research interests are infection control and prevention and antimicrobial resistant bacterial pathogens.

    • AB, Harvard University, 1990
    • MD, Johns Hopkins University School of Medicine, 1994

    • Internal Medicine Residency, University of California, San Francisco, 1994-1997
    • Chief Resident, University of California, San Francisco, 1997-1998
    • Infectious Diseases Fellowship, University of California, San Francisco, 1998 – 2001
    • Clinical Pharmacology Fellowship, University of California, San Francisco, 1999-2001

    • American Board of Internal Medicine, certified 1997, recertified 2007
    • American Board of Internal Medicine, subspecialty Infectious Diseases, certified 2000, recertified 2010

    Memberships & Affiliations:
    • Infectious Diseases Society of America, fellow
    • Society for Healthcare Epidemiology of America

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Guh AY, Hatfield KM, Winston LG, Martin B, Johnston H, Brousseau G, Farley MM, Wilson L, Perlmutter R, Phipps EC, Dumyati GK, Nelson D, Hatwar T, Kainer MA, Paulick AL, Karlsson M, Gerding DN, McDonald LC. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection with Greater Severity and Higher Recurrence Rates. Clin Infect Dis. 2019 Jan 07. PMID: 30615074.
      View in: PubMed
    2. Geha RM, Dhaliwal G, Winston LG, Kickler TS, Manesh R. Overcoming the Barrier. N Engl J Med. 2018 12 06; 379(23):2256-2261. PMID: 30575451.
      View in: PubMed
    3. Chaisson LH, Duong D, Cattamanchi A, Roemer M, Handley MA, Schillinger D, Sur M, Pham P, Lin MA, Goldman LE, Quan J, Perez S, Healy M, Higashi J, Winston L, Haller B, Luetkemeyer AF, Davis JL. Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital. JAMA Intern Med. 2018 Oct 01; 178(10):1380-1388. PMID: 30178007.
      View in: PubMed
    4. Vaisman A, Jula M, Wagner J, Winston LG. Examining the association between hospital-onset Clostridium difficile infection and multiple-bed room exposure: a case-control study. Infect Control Hosp Epidemiol. 2018 Sep; 39(9):1068-1073. PMID: 30060776.
      View in: PubMed
    5. Guh AY, Mu Y, Baggs J, Winston LG, Bamberg W, Lyons C, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, Dumyati G. Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015. Am J Infect Control. 2018 Jul; 46(7):840-842. PMID: 29329918.
      View in: PubMed
    6. Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, McDonald LC. Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study. Open Forum Infect Dis. 2017; 4(4):ofx171. PMID: 29732377.
      View in: PubMed
    7. Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC. Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes. Open Forum Infect Dis. 2016 Jan; 3(1):ofv196. PMID: 26798767; PMCID: PMC4719744.
    8. Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC. Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection. Open Forum Infect Dis. 2015 Sep; 2(3):ofv113. PMID: 26509182; PMCID: PMC4551478.
    9. Lessa FC, Winston LG, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 06 11; 372(24):2369-70. PMID: 26061850.
      View in: PubMed
    10. Isaacson D, Haller B, Leslie H, Roemer M, Winston L. Novel handwashes are superior to soap and water in removal of Clostridium difficile spores from the hands. Am J Infect Control. 2015 May 01; 43(5):530-2. PMID: 25952050.
      View in: PubMed
    11. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 Feb 26; 372(9):825-34. PMID: 25714160.
      View in: PubMed
    12. Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK. Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations. Open Forum Infect Dis. 2014 Sep; 1(2):ofu048. PMID: 25734120; PMCID: PMC4281776.
    13. See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis. 2014 May; 58(10):1394-400. PMID: 24604900; PMCID: PMC4697926.
    14. Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston HL, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics. 2014 Apr; 133(4):651-8. PMID: 24590748.
      View in: PubMed
    15. Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, Johnston H, Nadle J, Winston L, Gerding DN, McDonald LC, Lessa FC. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis. 2013 Nov; 57(9):1304-7. PMID: 23899677.
      View in: PubMed
    16. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013 Jul 22; 173(14):1359-67. PMID: 23780507.
      View in: PubMed
    17. Doernberg SB, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis. 2012 Sep; 55(5):615-20. PMID: 22563022; PMCID: PMC3491851.
    18. Doernberg SB, Winston LG. Risk factors for acquisition of extended-spectrum ß-lactamase-producing Escherichia coli in an urban county hospital. Am J Infect Control. 2012 Mar; 40(2):123-7. PMID: 21775020.
      View in: PubMed
    19. Chew KW, Yen IH, Li JZ, Winston LG. Predictors of pneumonia severity in HIV-infected adults admitted to an Urban public hospital. AIDS Patient Care STDS. 2011 May; 25(5):273-7. PMID: 21488749; PMCID: PMC4056456.
    20. Winston L, Chambers H. Coming home with MRSA. Arch Intern Med. 2009 Aug 10; 169(15):1379-80. PMID: 19667300.
      View in: PubMed
    21. Jain V, Yang MH, Kovacicova-Lezcano G, Juhle LS, Bolger AF, Winston LG. Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect. 2008 Aug; 57(2):132-8. PMID: 18597851.
      View in: PubMed
    22. Dombrowski JC, Winston LG. Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections. J Infect. 2008 Aug; 57(2):110-5. PMID: 18533269; PMCID: PMC2579945.
    23. Li JZ, Winston LG, Moore DH, Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med. 2007 Sep; 120(9):783-90. PMID: 17765048.
      View in: PubMed
    24. Winston LG, Roemer M, Goodman C, Haller B. False-positive culture results from patient tissue specimens due to contamination of RPMI medium with Cryptococcus albidus. J Clin Microbiol. 2007 May; 45(5):1604-6. PMID: 17314221; PMCID: PMC1865871.
    25. Young LS, Winston LG. Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2006 Dec; 27(12):1304-12. PMID: 17152027.
      View in: PubMed
    26. Weems JJ, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug; 50(8):2751-5. PMID: 16870768; PMCID: PMC1538656.
    27. Winston LG, Bolger AF. Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis. Curr Cardiol Rep. 2006 Mar; 8(2):102-8. PMID: 16524536.
      View in: PubMed
    28. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy. 2006 Jan; 26(1):61-7. PMID: 16509027.
      View in: PubMed
    29. Winston LG, Felt SC, Huang WH, Chambers HF. Introduction of a waterless hand gel was associated with a reduced rate of ventilator-associated pneumonia in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2004 Dec; 25(12):1015-6. PMID: 15636285.
      View in: PubMed
    30. Winston LG, Charlebois ED, Pang S, Bangsberg DR, Perdreau-Remington F, Chambers HF. Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. Am J Infect Control. 2004 Dec; 32(8):462-9. PMID: 15573053.
      View in: PubMed
    31. Young LS, Perdreau-Remington F, Winston LG. Clinical, epidemiologic, and molecular evaluation of a clonal outbreak of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2004 Apr 15; 38(8):1075-83. PMID: 15095210.
      View in: PubMed
    32. Winston LG, Pang S, Haller BL, Wong M, Chambers HF, Perdreau-Remington F. API 20 strep identification system may incorrectly speciate enterococci with low level resistance to vancomycin. Diagn Microbiol Infect Dis. 2004 Apr; 48(4):287-8. PMID: 15062923.
      View in: PubMed
    33. Chambers HF, Winston LG. Mupirocin prophylaxis misses by a nose. Ann Intern Med. 2004 Mar 16; 140(6):484-5. PMID: 15023716.
      View in: PubMed
    34. Winston L, Benowitz N. Once-daily dosing of aminoglycosides: how much monitoring is truly required? Am J Med. 2003 Feb 15; 114(3):239-40. PMID: 12637142.
      View in: PubMed
    35. Winston LG, Bangsberg DR, Chambers HF, Felt SC, Rosen JI, Charlebois ED, Wong M, Steele L, Gerberding JL, Perdreau-Remington F. Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital. Am J Infect Control. 2002 Nov; 30(7):400-6. PMID: 12410216.
      View in: PubMed